Glucophage

Glucophage is a prescription medication that contains the active ingredient metformin hydrochloride. It is formulated as an oral tablet (strength and specific dosage form may vary) and is marketed in the European Union. As a member of the biguanide class, Glucophage is used to improve blood glucose control in adults with type 2 diabetes mellitus by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity.

Glucophage is indicated primarily for the management of type 2 diabetes mellitus in adults.

- Improves glycemic control as part of a comprehensive diabetes management plan that includes diet and exercise. - Can be used as monotherapy when metformin alone is sufficient to achieve target blood glucose levels. - May be combined with other oral antidiabetic agents or insulin when additional glucose lowering is needed. - Helps reduce the risk of diabetes‑related complications by maintaining more stable blood glucose concentrations. - Often prescribed for patients with overweight or obesity, as metformin may modestly aid weight management.

Side effects of Glucophage vary in frequency and severity; most are mild and transient, while rare reactions may require medical attention.

Common: - Gastrointestinal upset such as nausea, abdominal discomfort, or diarrhea. - Metallic taste in the mouth. - Decreased appetite. - Mild headache.

Serious: - Lactic acidosis, a rare but potentially life‑threatening condition characterized by rapid breathing, muscle pain, or unusual fatigue. - Severe skin reactions, including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Significant vitamin B12 deficiency with prolonged use.

Before starting Glucophage, certain health considerations and monitoring requirements should be reviewed with a healthcare professional.

- Assess renal function; metformin is contraindicated in severe renal impairment. - Evaluate liver function, as hepatic disease can increase the risk of lactic acidosis. - Use caution in patients with heart failure or a history of hypoxia. - Monitor blood glucose regularly to avoid hypoglycemia, especially when combined with other glucose‑lowering drugs. - Periodic assessment of vitamin B12 levels is recommended for long‑term therapy. - Discontinue before any radiographic studies that involve iodinated contrast agents.

Glucophage may interact with other medicines, affecting its efficacy or safety profile.

Avoid: - Iodinated contrast agents used in imaging studies; they can precipitate acute kidney injury and increase lactic acidosis risk. - Certain cationic drugs (e.g., trimethoprim, pyrimethamine) that may reduce metformin clearance. - Alcohol excess, which can potentiate lactic acidosis.

Use with caution: - Other antidiabetic agents, especially sulfonylureas or insulin, due to increased hypoglycemia risk. - Diuretics that may affect renal function and metformin elimination. - Corticosteroids, which can raise blood glucose and alter metformin dosing needs.